increased
development
treatment
taxing
roxadustat
studied
addition
included
requirement
dosing
developing
include
patient
base
increase
approved
generation
taxed
follows
dosed
stock
manufactured
approves
manufacture
applicant
related
potential
approval
generic
providing
marketing
level
including
studying
dos
applicable
tax
clinically
share
provides
developer
relating
china
trial
additional
manufacturing
general
effecting
marketed
approving
effective
generated
provided
effected
production
market
pricing
following
significance
includes
application
shared
provide
generating
generally
developed
provider
relate
effect
effectively
marketability
relation
current
esas
certain
required
develop
require
potentially
clinic
generous
generate
followed
esa
clinical
approve
based
follow
product
drug
sharing
significant
price
relates
requires
table
increasing
applicability
company
requiring
dose
regulatory
manufacturer
effectiveness
currently
study
